Patterson Companies, Inc. Share Price Berne S.E.

Equities

PD2

US7033951036

Medical Equipment, Supplies & Distribution

Delayed Berne S.E. 5-day change 1st Jan Change
- CHF -.--% Intraday chart for Patterson Companies, Inc. -.--% -.--%

Financials

Sales 2024 * 6.55B 5.83B 547B Sales 2025 * 6.74B 6B 563B Capitalization 2.03B 1.81B 169B
Net income 2024 * 188M 167M 15.7B Net income 2025 * 191M 170M 15.95B EV / Sales 2024 * 0.39 x
Net Debt 2024 * 519M 462M 43.35B Net Debt 2025 * 446M 397M 37.24B EV / Sales 2025 * 0.37 x
P/E ratio 2024 *
11.3 x
P/E ratio 2025 *
10.8 x
Employees -
Yield 2024 *
4.67%
Yield 2025 *
4.74%
Free-Float 88.63%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 56 29/18/29
Director of Finance/CFO 46 01/18/01
Compliance Officer - 01/20/01
Members of the board TitleAgeSince
Chairman 74 01/06/01
Director/Board Member 68 01/11/01
Chief Executive Officer 56 29/18/29
More insiders
Patterson Companies, Inc. is a value-added specialty distributor serving the United States and Canadian dental supply markets and the United States, Canadian and United Kingdom animal health supply markets. The Company’s segments include Dental, Animal Health and Corporate. Dental segment provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals throughout North America. Animal Health segment is a full-line distributor in North America and the United Kingdom. of animal health products, services, and technologies to both the production-animal and companion-pet markets. The Company provides relief services. It also provides pasteurizing equipment and single-use bags that allow dairy producers to produce, store and feed colostrum for newborn calves, as well as product offerings for beef cattle producers.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
22.63 USD
Average target price
28.9 USD
Spread / Average Target
+27.71%
Consensus